CELU — Celularity Inc

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1752828 ·
Last close
$0.57
Market Cap
$18.53M
52W High
$2.55
52W Low
$0.55
ADV30
146,555
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 5,432,000 3,085,000 -4,237,000 706,000 96,167,000 586,000 131,698,000
Mar 2026 3,846,000 2,394,000 -10,133,000 874,000 99,480,000 368,000 134,741,000
Dec 2025 4,104,000 -3,270,000 -22,058,000 -24,362,000 107,329,000 6,175,000 145,391,000
Sep 2025 5,284,000 1,380,000 -12,900,000 -23,076,000 114,239,000 120,000 134,333,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-8,817,000
Investing CF
$0
Financing CF
$8,987,000
CapEx
—
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.72
As of
2026-10-25

Balance + Analyst (yfinance extras)

Retained Earnings
$-990,609,000
Inventory
$477,000
Receivables
$4,781,000
ST Investments
—
EBIT TTM
$-66,416,000
Pretax Income TTM
$-71,085,000
Interest Exp TTM
$4,669,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$18,666,000
EBITDA
$-42,565,000
Free Cash Flow
$-26,285,000
Enterprise Value
$102,916,032
Total Cash
$586,000
Total Debt
$69,833,000
Shares Out
32,449,767
Trailing EPS
$-1.69
Book Value
$-1.21
ROE
—
ROA
-27.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 26,550,000 -61,308,000 -91,716,000 107,329,000 145,391,000 -38,062,000 -13,254,000
Dec 2024 54,220,000 -38,551,000 -57,892,000 132,682,000 123,845,000 8,837,000 -6,401,000
Dec 2023 22,771,000 -76,479,000 -196,295,000 143,889,000 102,929,000 40,960,000 -38,685,000
Dec 2022 17,975,000 -148,267,000 14,192,000 401,066,000 202,165,000 198,901,000 -137,876,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$18,970,000
NetIncome TTM
$-71,088,000
OpCashFlow TTM
—
Assets (Latest)
$99,480,000
Forward EPS
$-0.57

Peers — same industry

TickerNameMarket CapLastDaily %
EDSA Edesa Biotech, Inc. $18.90M $1.96 —
ATOS ATOSSA THERAPEUTICS, INC. $18.96M $1.90 —
PVCT PROVECTUS BIOPHARMACEUTICALS, INC. $17.90M $0.04 —
LPCN Lipocine Inc. $17.72M $1.60 —
IGC IGC Pharma, Inc. $19.43M $0.19 —

News headlines (Yahoo Finance, 1h cache)

Celularity and Vesalius Longevity Labs Sign Exclusive Collaboration for Peptual® Peptide APIs Manufactured in the United States
2026-10-29 13:00 · Yahoo
Celularity Regains Compliance with Nasdaq Periodic Reporting Requirement
2026-10-22 12:00 · Yahoo
Celularity Highlights Anticipated Quarter One 2027 Opening of Fontaine Vitale as Strategic Partner
2026-09-30 15:57 · Yahoo
Celularity Announces Naveen Jain to Join Board of Directors
2026-09-29 12:30 · Yahoo
Celularity Announces Over $10 Million Initial Financing Closing as Part of Up to $28 Million Recapitalization to Accelerate Growth Following Significant Operating Improvements
2026-09-24 13:15 · Yahoo
Celularity Signs U.S. Manufacturing Collaboration With Potential $300 Million Purchase Opportunity
2026-08-27 14:27 · Yahoo
Celularity Provides Update Regarding Nasdaq Listing Compliance
2026-08-25 23:59 · Yahoo
NexGel Files to Register 15.25 Million Shares From Note Conversions
2026-08-20 17:35 · Yahoo
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
2026-05-01 20:30 · Yahoo
Celularity Receives Nasdaq Notice Regarding Form 10-Q
2026-05-29 21:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.